Three inspiring days at EACR 2025 in Lisbon are behind us, and we’re excited about the impact this event had for us. It proved to be a well-focused platform to strengthen visibility and connect with key players in cancer research.
Our colleague Adrien Lecocq represented us on-site and did an excellent job engaging with researchers, sharing insights, and fostering new collaborations throughout the conference.
We saw strong interest in our cancer-related biospecimens – particularly tissues, cells, PBMCs, and our proprietary innovation, homoGel®. The discussions around 3D models such as spheroids and organoids also opened up promising new perspectives.
Thank you to everyone who visited us – we truly value the conversations and connections and look forward to what’s ahead.
